Skip to main content
Premium Trial:

Request an Annual Quote

A. Menarini to Distribute Credo Diagnostics Coronavirus Assay Kit, Respiratory Infection Assays

NEW YORK – A. Menarini Diagnostics and Credo Diagnostics Biomedical announced on Thursday an exclusive distribution agreement for Credo's SARS-CoV-2 assay kit and other assays for diagnosing respiratory syncytial virus and Group Strep A.

The tests run on Credo's VitaPCR, a CE-marked point-of-care molecular platform. The firms said that results for the coronavirus test, which use a nasal or oropharyngeal sample, can be achieved in 20 minutes. The test also recently received the CE mark

According to Credo's website, the VitaPCR requires two minutes of hands-on time and does not require extra equipment such as refrigeration.

Financial and other terms of the deal were not disclosed.

The Scan

ChatGPT Does As Well As Humans Answering Genetics Questions, Study Finds

Researchers in the European Journal of Human Genetics had ChatGPT answer genetics-related questions, finding it was about 68 percent accurate, but sometimes gave different answers to the same question.

Sequencing Analysis Examines Gene Regulatory Networks of Honeybee Soldier, Forager Brains

Researchers in Nature Ecology & Evolution find gene regulatory network differences between soldiers and foragers, suggesting bees can take on either role.

Analysis of Ashkenazi Jewish Cohort Uncovers New Genetic Loci Linked to Alzheimer's Disease

The study in Alzheimer's & Dementia highlighted known genes, but also novel ones with biological ties to Alzheimer's disease.

Tara Pacific Expedition Project Team Finds High Diversity Within Coral Reef Microbiome

In papers appearing in Nature Communications and elsewhere, the team reports on findings from the two-year excursion examining coral reefs.